✦ LIBER ✦

The Saitohin ‘Q7R’ polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts

✍ Scribed by Lorraine N Clark; Gilberto Levy; Ming-Xin Tang; Helen Mejia-Santana; Alejandra Ciappa; Benjamin Tycko; Lucien J Cote; Elan D Louis; Richard Mayeux; Karen Marder

Book ID: 117474049
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 82 KB
Volume: 347
Category: Article
ISSN: 0304-3940
DOI: 10.1016/s0304-3940(03)00635-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No evidence for an association between S

No evidence for an association between Saitohin Q7R polymorphism and Alzheimer's disease

✍ Lynnette Cook; Carol E. Brayne; Douglas Easton; John Grimley Evans; John Xuereb; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

Genetic analysis of tumor necrosis facto

Genetic analysis of tumor necrosis factor-α (TNF-α) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease

✍ Binbin Wang; Sirui Zhou; Ze Yang; Yan-chen Xie; Jing Wang; Peng Zhang; Zeping Lv 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Association of the Tau haplotype with Pa

Association of the Tau haplotype with Parkinson's disease in the Greek population

✍ Liana Fidani; Kallirhoe Kalinderi; Sevasti Bostantjopoulou; Jordi Clarimon; Anto 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

## Abstract We compared the distribution of the __Tau__ H1 haplotype and related subhaplotypes in a group of clinically diagnosed Parkinson's disease patients (n = 133) and in control individuals (n = 113) from northern Greece. We were able to detect a statistically significant overrepresentation o

The Cathepsin D rs17571 polymorphism: ef

The Cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease

✍ Matthias Riemenschneider; Kaj Blennow; Stefan Wagenpfeil; Niels Andreasen; Jonat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Communicated by Michael Dean The lysosomal protease cathepsin D (CtsD, EC 3.4.23.5; gene, CTSD) has been associated with Alzheimer disease (AD) due to its cerebral expression being increased early in the course of AD; additionally, a CTSD exon 2 polymorphism (rs17571; NT\_009237.17:g.569834T4C)